Article

Polypharmacological drug design opportunities against Parkinson's disease

2022-10-17

Abstract excerpt

<h4>Background: </h4> : Parkinson's disease is an attractive disease model to extend research towards a better understanding of the interrelationship between genes and the environment (exposome) therefore is an ideal model for a polypharmacological approach due to its clinical heterogeneity. <h4>Methods: </h4> : In this paper, we present a series of polypharmacological chemical scaffolds extracted from ChEMBL 30...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ec7d988c-d87b-568b-9984-0cc82284d026
DOI: 10.12688/f1000research.124160.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Polypharmacological drug design opportunities against Parkinson's diseaseDOI 10.12688/f1000research.124160.1Read

Repurposing the Memory-promoting Meclofenoxate Hydrochloride as a Treatment for Parkinson‘s Disease through Integrative Multi-omics analysisSemantic proximity Read

Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s DiseaseSemantic proximity Read

Drug Repurposing for Parkinson’s Disease: A Large-Scale Multi-Cohort StudySemantic proximity Read

Decoding Early Parkinson's: A Network-Based Approach to Drug Target IdentificationSemantic proximity Read

Pharmacogenomics of Alzheimer’s and Parkinson’s diseasesSemantic proximity Read

A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics?Semantic proximity Read

A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's disease.Semantic proximity Read

Integration of National Health Insurance Claim Data and Animal Models Reveals Fexofenadine as a Promising Repurposed Drug for Parkinson’s DiseaseSemantic proximity Read

Explores the network pharmacology and molecular docking-based prediction of the molecular target and signaling pathways of Piperine in the treatment of Parkinson's diseaseSemantic proximity Read

Parkinson’s Disease Pharmacogenomics: New Findings and PerspectivesSemantic proximity Read

Identification and Validation of N-Acetylputrescine in Combination With Non-Canonical Clinical Features As a Parkinson’s Disease Biomarker PanelSemantic proximity Read

Finding drug targeting mechanisms with genetic evidence for Parkinson’s diseaseSemantic proximity Read